Medication info
Mikatan Plus Tablet 80/25 mg

Mikatan Plus Tablet 80/25 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletHydrochlorothiazide›25mg / 1 tablet
Manufacturer / importer
SS Pharm Co., Ltd.
Appearance
An oval-shaped tablet made of two layers, one white and one yellow, with possible yellow speckles on the white layer.
Packaging
30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 201005059 · Notified 2010.08.17

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take this medicine once daily with a beverage, with or without food. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the doses of the individual components be adjusted separately for each patient. When clinically appropriate, switching directly from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg plus hydrochlorothiazide 12.5mg as separate tablets or with the combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is required in patients with mild-to-moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment Use this medicine with caution in patients with mild-to-moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine once daily. Do not administer this medicine to patients with severe hepatic impairment (see Precautions for Use 2.). Thiazide diuretics should be used with caution in patients with impaired hepatic function. Elderly patients No dose adjustment is required.
Child dose
The safety and efficacy of this medicine have not been established in children under 18 years of age.

Ingredients

Manufacturer
SS Pharm Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

This medication is used for the treatment of essential hypertension, administered to patients whose blood pressure is not adequately controlled with a single agent combination or fixed-dose combination of 80 mg Telmisartan and 12.5 mg Hydrochlorothiazide to improve blood pressure control.

How to take

Adult dose

Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take this medicine once daily with a beverage, with or without food. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the doses of the individual components be adjusted separately for each patient. When clinically appropriate, switching directly from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg plus hydrochlorothiazide 12.5mg as separate tablets or with the combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is required in patients with mild-to-moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment Use this medicine with caution in patients with mild-to-moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine once daily. Do not administer this medicine to patients with severe hepatic impairment (see Precautions for Use 2.). Thiazide diuretics should be used with caution in patients with impaired hepatic function. Elderly patients No dose adjustment is required.

Child dose

The safety and efficacy of this medicine have not been established in children under 18 years of age.

Precautions

This medication should not be used during pregnancy, especially in the second and third trimesters, due to the risk of serious injury or death to the fetus. Patients allergic to the components of this medicine or those with certain liver or kidney diseases should not take it. Pregnant and nursing women should also not be administered this medication. Elderly patients or those with high potassium levels in the blood, liver, or heart problems should use this medication cautiously. The Hydrochlorothiazide component can increase the risk of skin cancer, so sun exposure should be avoided during treatment, and skin conditions should be monitored frequently. As this medication lowers blood pressure, symptoms such as dizziness, hypotension, and fainting can occur, and caution is required when driving or operating machinery. Regular monitoring of electrolyte levels in the blood and kidney function is necessary during treatment, paying particular attention to changes in potassium levels. Interactions may occur when combined with other antihypertensives, diuretics, lithium, non-steroidal anti-inflammatory drugs, etc., so it is important to consult a doctor. Overdose can lead to symptoms such as hypotension, electrolyte imbalance, and dehydration, requiring immediate medical attention. This medication is not recommended for children under 18, and should be administered cautiously in the elderly. When storing, keep it out of the reach of children, and use it immediately after removing it from the package.

Side effects

  • Bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorders
Show 188 more
  • dizziness
  • syncope
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory pain
  • pneumonia
  • pulmonary edema
  • diarrhea
  • dry mouth
  • distention
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • liver dysfunction
  • hepatic impairment
  • angioedema
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • urticaria
  • back pain
  • muscle spasms
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased blood uric acid
  • increased blood creatinine
  • increased blood creatine phosphokinase
  • elevated liver enzymes
  • upper respiratory tract infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hypersensitivity
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • bradycardia
  • cough
  • interstitial lung disease
  • dry mouth
  • abdominal discomfort
  • angioedema
  • eczema
  • drug rash
  • toxic epidermal necrolysis
  • bone pain
  • renal impairment
  • asthenia
  • influenza-like illness
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • sialadenitis
  • non-melanoma skin cancer
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • aplastic anemia
  • hypomagnesemia
  • hyperlipidemia
  • decreased appetite
  • hyperglycemia
  • hypercalcemia
  • hypochloremic alkalosis
  • headache
  • yellow vision
  • acute myopia
  • angle-closure glaucoma
  • choroidal effusion
  • necrotizing vasculitis
  • acute respiratory distress syndrome
  • nausea
  • pancreatitis
  • jaundice
  • bile stasis
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • systemic lupus erythematosus
  • acute renal failure
  • diabetes
  • renal impairment
  • asthenia
  • fever
  • nausea
  • gastrointestinal hemorrhage
  • esophagitis
  • headache
  • tremor
  • facial flushing
  • malaise
  • fatigue
  • anxiety
  • proteinuria
  • rash
  • pruritus
  • myalgia
  • floating sensation
  • lip and hand tremor
  • sensory hypersensitivity
  • gingival disease
  • lip dryness
  • decreased vision
  • hypotension
  • tachycardia
  • bradycardia
  • hypokalemia
  • hypochloremia
  • dehydration
  • nausea
  • somnolence
  • muscle cramps
  • cardiac arrhythmia
  • hypotension
  • tachycardia
  • bradycardia
  • hypokalemia
  • hypochloremia
  • dehydration
  • nausea
  • somnolence
  • muscle cramps
  • cardiac arrhythmia
  • abdominal pain
  • gastritis
  • vomiting
  • angioedema
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • urticaria
  • back pain
  • muscle spasms
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased blood uric acid
  • increased blood creatinine
  • increased blood creatine phosphokinase
  • elevated liver enzymes
  • dizziness
  • diarrhea
  • cough
  • headache
  • nausea
  • gastrointestinal hemorrhage
  • esophagitis
  • fatigue
  • weight loss
  • proteinuria
  • pruritus
  • myalgia
  • floating sensation
  • lip dryness
  • decreased vision
  • hypoglycemia
  • intestinal edema
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture. It is best to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

An oval-shaped tablet made of two layers, one white and one yellow, with possible yellow speckles on the white layer.

Package unit

30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.